Civic Intelligence

International Medica Foundation

990 • Fiscal year 2012 • EIN 26-1556795

Dec 01, 2011 to Nov 30, 2012 • Filed on Apr 13, 2013

421 1st Avenue SW No 30455902
Siviq Scores

Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.

Liabilities / Assets

91st percentile

0.96x

Higher debt load relative to assets than 91% of similar nonprofits.

2012 filings • 501(c)3 • $500k-$1M nonprofits • Source year 2012

Liabilities / Revenue

Score unavailable

No value available

Liabilities-to-revenue requires both liabilities and revenue on this filing.

Source year 2012

Net Margin

Score unavailable

No value available

Net margin requires both revenue and expenses on this filing.

Source year 2012

Top Officer Pay

Score unavailable

No value available

This filing does not contain officer compensation rows.

Source year 2012

Asset Growth

6th percentile

-31%

Faster asset growth than 6% of similar nonprofits.

2012 filings • 501(c)3 • $500k-$1M nonprofits • Annualized from 2011 to 2012

Revenue Growth

Score unavailable

No value available

No valid filing value is available for this score.

Assets

Down

$518,547

Down $1,443,302 (-74%) from 2010

Net Assets

Down

$18,547

Down $1,943,302 (-99%) from 2010

Liabilities

Up

$500,000

Up $500,000 from 2010

Revenue

-

No earlier filing loaded for comparison.

Expenses

Down

$724,928

Down $2,596,393 (-78%) from 2010

Net Income

-

No earlier filing loaded for comparison.

Historical Trend

Balance Sheet Trend

The highlighted filing sits inside the broader history for assets, liabilities, and net assets.

$2.0M$1.0M$0-$1.0MAssets 2010: $1,961,849Liabilities 2010: $0Net Assets 2010: $1,961,8492010Assets 2012: $518,547Liabilities 2012: $500,000Net Assets 2012: $18,5472012Assets 2013: $346,679Liabilities 2013: $610,000Net Assets 2013: -$263,3212013Assets 2014: $249,825Liabilities 2014: $500,000Net Assets 2014: -$250,1752014Assets 2015: $1,013,673Liabilities 2015: $500,000Net Assets 2015: $513,6732015Assets 2016: $626,403Liabilities 2016: $500,000Net Assets 2016: $126,4032016Assets 2017: $159,208Liabilities 2017: $500,000Net Assets 2017: -$340,7922017Assets 2018: $63,726Liabilities 2018: $500,000Net Assets 2018: -$436,2742018Assets 2019: $72,478Liabilities 2019: $500,000Net Assets 2019: -$427,5222019

Highlighted filing

2012

Assets$518,547
Liabilities$500,000
Net Assets$18,547

Operations Trend

Revenue, expenses, and net income across loaded years, with this filing highlighted.

$4.0M$3.0M$2.0M$1.0M$0-$1.0MExpenses 2010: $3,321,3212010Expenses 2012: $724,9282012Expenses 2013: $581,9212013Revenue 2014: $21Expenses 2014: $160,256Net Income 2014: -$160,2352014Revenue 2015: $1,405,476Expenses 2015: $641,628Net Income 2015: $763,8482015Revenue 2016: $19,413Expenses 2016: $406,683Net Income 2016: -$387,2702016Revenue 2017: $106,420Expenses 2017: $573,615Net Income 2017: -$467,1952017Revenue 2018: $105,241Expenses 2018: $200,723Net Income 2018: -$95,4822018Revenue 2019: $107,006Expenses 2019: $98,254Net Income 2019: $8,7522019

Highlighted filing

2012

Revenue-
Expenses$724,928
Net Income-
Jump To
Filing Snapshot
Filing Period
Dec 1, 2011 to Nov 30, 2012
Signed
Apr 13, 2013
Return Version
2011v1.5
Gross Receipts
$84,333
Mission and Program Overview

Major Activities

Activity 2
International medica has been working with the national institute of allergy and infectious diseases (niaid) national institutes of health (nih), and idt biologika gmbh, its vaccine manufacturer in germany, on a new, proprietary, liquid, heat-stable formulation of rotashield.a major constraint in achieving high immunization rates in less-developed countries is the requirement for a cold chain -- maintaining proper refrigeration of the vaccine product to ensure its effectiveness. This new rotashield liquid formulation has the potential to eliminate the need for a cold chain, which would significantly reduce the distribution and storage costs of the vaccine. All of the currently marketed rotavirus vaccines require refrigeration. Elimination of the need for the cold-chain for vaccines is also of great interest to the vaccine community worldwide, especially in the developing world.a typical liquid rotavirus suspension would generally lose its effectiveness after approximately one week of storage at 37 degrees celsius (98.6 degrees fahrenheit), whereas the new rotashield liquid formulation has shown stability for 6 months at this temperature even when an antacid is present. This same proprietary technology may be adaptable for use with other oral vaccines. The foundation has been actively seeking intellectual property protection of its advanced formulation.intl-medica expanded its patent protection of its new formulation and filed for extensive world-wide patent protection of its formulation. The foundation also began discussions with numerous groups who are interested in a license of this technology to ultimately utilize this technology in vaccine delivery.
Activity 3
The foundation has continued to engage in discussions with researchers at the national institute of health (nih) in bethesda, maryland, the infectious disease research institute (idri) in seattle, washington and the mayo clinic in rochester, minnesota, with regard to potential vaccines to be developed and other possible global disease issues to be addressed. The foundation is actively examining the possibilities of licensing and developing a vaccine for dengue.
Filing and Contact Details

Filer

EIN
26-1556795
Raw XML AppendixShowing 400 of 420 raw XML fields

This appendix keeps the raw XML leaves available for debugging and edge-case review. The human report above is the primary experience.

Path#Value
IRS990/AccountantCompileOrReview00
IRS990/AccountsReceivable/BOY0129095
IRS990/AccountsReceivable/EOY00
IRS990/ActivitiesConductedPartnership00
IRS990/Activity2/Description0INTERNATIONAL MEDICA HAS BEEN WORKING WITH THE NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES (NIAID) NATIONAL INSTITUTES OF HEALTH (NIH), AND IDT BIOLOGIKA GMBH, ITS VACCINE MANUFACTURER IN GERMANY, ON A NEW, PROPRIETARY, LIQUID, HEAT-STABLE FORMULATION OF ROTASHIELD.A MAJOR CONSTRAINT IN ACHIEVING HIGH IMMUNIZATION RATES IN LESS-DEVELOPED COUNTRIES IS THE REQUIREMENT FOR A COLD CHAIN -- MAINTAINING PROPER REFRIGERATION OF THE VACCINE PRODUCT TO ENSURE ITS EFFECTIVENESS. THIS NEW ROTASHIELD LIQUID FORMULATION HAS THE POTENTIAL TO ELIMINATE THE NEED FOR A COLD CHAIN, WHICH WOULD SIGNIFICANTLY REDUCE THE DISTRIBUTION AND STORAGE COSTS OF THE VACCINE. ALL OF THE CURRENTLY MARKETED ROTAVIRUS VACCINES REQUIRE REFRIGERATION. ELIMINATION OF THE NEED FOR THE COLD-CHAIN FOR VACCINES IS ALSO OF GREAT INTEREST TO THE VACCINE COMMUNITY WORLDWIDE, ESPECIALLY IN THE DEVELOPING WORLD.A TYPICAL LIQUID ROTAVIRUS SUSPENSION WOULD GENERALLY LOSE ITS EFFECTIVENESS AFTER APPROXIMATELY ONE WEEK OF STORAGE AT 37 DEGREES CELSIUS (98.6 DEGREES FAHRENHEIT), WHEREAS THE NEW ROTASHIELD LIQUID FORMULATION HAS SHOWN STABILITY FOR 6 MONTHS AT THIS TEMPERATURE EVEN WHEN AN ANTACID IS PRESENT. THIS SAME PROPRIETARY TECHNOLOGY MAY BE ADAPTABLE FOR USE WITH OTHER ORAL VACCINES. THE FOUNDATION HAS BEEN ACTIVELY SEEKING INTELLECTUAL PROPERTY PROTECTION OF ITS ADVANCED FORMULATION.INTL-MEDICA EXPANDED ITS PATENT PROTECTION OF ITS NEW FORMULATION AND FILED FOR EXTENSIVE WORLD-WIDE PATENT PROTECTION OF ITS FORMULATION. THE FOUNDATION ALSO BEGAN DISCUSSIONS WITH NUMEROUS GROUPS WHO ARE INTERESTED IN A LICENSE OF THIS TECHNOLOGY TO ULTIMATELY UTILIZE THIS TECHNOLOGY IN VACCINE DELIVERY.
IRS990/Activity2/Expense0108087
IRS990/Activity3/Description0THE FOUNDATION HAS CONTINUED TO ENGAGE IN DISCUSSIONS WITH RESEARCHERS AT THE NATIONAL INSTITUTE OF HEALTH (NIH) IN BETHESDA, MARYLAND, THE INFECTIOUS DISEASE RESEARCH INSTITUTE (IDRI) IN SEATTLE, WASHINGTON AND THE MAYO CLINIC IN ROCHESTER, MINNESOTA, WITH REGARD TO POTENTIAL VACCINES TO BE DEVELOPED AND OTHER POSSIBLE GLOBAL DISEASE ISSUES TO BE ADDRESSED. THE FOUNDATION IS ACTIVELY EXAMINING THE POSSIBILITIES OF LICENSING AND DEVELOPING A VACCINE FOR DENGUE.
IRS990/Activity3/Expense021617
IRS990/ActivityOrMissionDescription0THE INTERNATIONAL MEDICA FOUNDATION IS COMMITTED TO THE DEVELOPMENT OF SAFE AND COST EFFECTIVE HEALTHCARE PRODUCTS FOR FAMILIES IN NEED IN NEGLECTED POPULATIONS AROUND THE WORLD. ALL ACTIVITIES OF THE FOUNDATION ARE IN THE FIELD OF MEDICAL RESEARCH RELATED TO THE DEVELOPMENT OF VACCINES AND RELATED PRODUCTS, SERVICES, THERAPEUTICS, DIAGNOSTICS AND DRUG DELIVERY METHODS FOR DISEASES AFFECTING THE WORLD POPULATION WITH PARTICULARLY CATASTROPHIC EFFECTS ON THE LIVES OF FAMILIES IN THE DEVELOPING WORLD.
IRS990/AddressPrincipalOfficerUS/AddressLine10421 1ST AVENUE SW NO 304
IRS990/AddressPrincipalOfficerUS/City0ROCHESTER
IRS990/AddressPrincipalOfficerUS/State0MN
IRS990/AddressPrincipalOfficerUS/ZIPCode055902
IRS990/AnnualDisclosureCoveredPersons01
IRS990/BenefitsPaidToMembersCY00
IRS990/BenefitsPaidToMembersPriorYear00
IRS990/BsnssRltnshpThruFamilyMember00
IRS990/BsnssRltnshpWithOrganization00
IRS990/CashNonInterestBearing/BOY03329
IRS990/CashNonInterestBearing/EOY03256
IRS990/ChangesToOrganizingDocs00
IRS990/CollectionsOfArt00
IRS990/CompCurrentOfficersDirectors/ManagementAndGeneral069000
IRS990/CompCurrentOfficersDirectors/ProgramServices0336000
IRS990/CompCurrentOfficersDirectors/Total0405000
IRS990/CompensationFromOtherSources00
IRS990/CompensationProcessCEO01
IRS990/CompensationProcessOther01
IRS990/ConferencesMeetings/ManagementAndGeneral035
IRS990/ConferencesMeetings/Total035
IRS990/ConflictOfInterestPolicy01
IRS990/ConservationEasements00
IRS990/ConsolidatedAuditFinancialStmt00
IRS990/ContractorCompensation/AddressOfContractor/AddressUS/AddressLine10441 VINE STREET SUITE 1200
IRS990/ContractorCompensation/AddressOfContractor/AddressUS/City0CINCINNATI
IRS990/ContractorCompensation/AddressOfContractor/AddressUS/State0OH
IRS990/ContractorCompensation/AddressOfContractor/AddressUS/ZIPCode045202
IRS990/ContractorCompensation/Compensation0166143
IRS990/ContractorCompensation/DescriptionOfServices0CONTRACT RESEARCH ORGANIZATION
IRS990/ContractorCompensation/NameOfContractor/NameBusiness/BusinessNameLine10INC RESEARCH INC (FORMERLY KENDLE INTL
IRS990/ContributionsGrantsCurrentYear00
IRS990/ContributionsGrantsPriorYear0500000
IRS990/CreditCounseling00
IRS990/DecisionsSubjectToApproval00
IRS990/DeductibleContributionsOfArt00
IRS990/DeductibleNonCashContributions00
IRS990/DelegationOfManagementDuties00
IRS990/DepreciationDepletion/ManagementAndGeneral0497
IRS990/DepreciationDepletion/Total0497
IRS990/DescribedIn501C301
IRS990/Description0THE PRIMARY PURPOSE OF INTL-MEDICA IS THE DEVELOPMENT AND DELIVERY OF AN ORAL ROTAVIRUS VACCINE FOR THE PREVENTION OF ROTAVIRUS-RELATED MORBIDITY AND DEATHS IN THE DEVELOPING WORLD. GLOBALLY, INFECTIONS FROM ROTAVIRUS ACCOUNT FOR AN ESTIMATED 125 MILLION CASES OF DIARRHEA EACH YEAR, RESULTING IN THE DEATHS OF APPROXIMATELY 500,000 INFANTS ANNUALLY FROM A DISEASE THAT IS HIGHLY PREVENTABLE WITH AN ORAL VACCINE. WORLDWIDE, ROTAVIRUS INFECTS EVERY CHILD IN THE WORLD IN THEIR FIRST FEW YEARS OF LIFE AND SENDS 1 CHILD IN EVERY 5 TO 8 TO A CLINIC FOR TREATMENT, 1 IN EVERY 58 TO A HOSPITAL, AND 1 IN 250-300 DIE FROM DEHYDRATING DIARRHEA. ROTAVIRUS IS THE CAUSE OF 30% TO 40% OF THE HOSPITALIZATIONS FOR DIARRHEA IN CHILDREN LESS THAN FIVE YEARS OF AGE AND RESULTS IN OVER 1,600 DEATHS EACH DAY IN DEVELOPING COUNTRIES WHERE MEDICAL CARE IS LIMITED AND MALNUTRITION IS PREVALENT. ROTAVIRUS VACCINE ACTIVITIES. BRIEF HISTORY: THE ROTAVIRUS VACCINE, KNOWN AS ROTASHIELD, WAS INVENTED AND INITIALLY DEVELOPED BY THE NATIONAL INSTITUTES OF HEALTH OF THE UNITED STATES (NIH). FROM ITS INCEPTION IN DECEMBER 2007 AND CONTINUING CURRENTLY, INTERNATIONAL MEDICA PERSONNEL HAVE BEEN WORKING EXTENSIVELY ALONGSIDE THE NIH AND A VACCINE MANUFACTURER TO COMPLETE A FINALIZED VACCINE PRODUCT ULTIMATELY FOR USE IN THE NEGLECTED POPULATIONS OF THE WORLD. VACCINE MANUFACTURED FOR CLINICAL TRIALS WAS TESTED TO ENSURE IT MET ALL POTENCY STANDARDS AND ALL REGULATORY REQUIREMENTS PRIOR TO BEING RELEASED FOR USE. INTERNATIONAL MEDICA, WORKING WITH THE NIH, ACTIVELY PARTICIPATED IN THE ONGOING DEVELOPMENT OF THE MANUFACTURING PROCESS, ENSURING THAT ANY CHANGES TO THE MANUFACTURING PROCESS MET ALL REGULATORY REQUIREMENTS. PHASE II CLINICAL TRIAL: WORKING WITH A NUMBER OF GROUPS INTERNATIONALLY, THE FOUNDATION CONDUCTED A PHASE II CLINICAL TRIAL THE PURPOSE OF WHICH WAS TO ALLOW INTERNATIONAL MEDICA TO DETERMINE IF THE ROTASHIELD VACCINE, WHEN GIVEN IN THE NEONATAL DELIVERY REGIMEN, STIMULATES THE IMMUNE RESPONSE OF INFANTS TO PROVIDE AN ADEQUATE PROTECTION AGAINST THE ROTAVIRUS. GIVING THE VACCINE TO NEONATES WOULD ALLOW MORE CHILDREN TO RECEIVE THE VACCINE, AS CHILDREN IN DEVELOPING COUNTRIES ARE MOST LIKELY TO HAVE INTERACTION WITH HEALTH CARE PROVIDERS IN THE FIRST DAYS IMMEDIATELY AFTER BIRTH. STARTING IMMUNIZATIONS AT OR NEAR BIRTH WOULD ALSO PROTECT INFANTS EARLIER IN LIFE.IN EARLY 2ND QUARTER OF 2009, MANUFACTURE OF THE FINAL ROTASHIELD VACCINE WAS COMPLETED AND READY FOR THE CLINICAL TRIAL. THIS PHASE II CLINICAL TRIAL ULTIMATELY SCREENED APPROXIMATELY 1,051 CHILDREN FOR THE TRIAL WITH MULTI-ARM END-POINTS. A TOTAL OF 949 INFANTS COMPLETED THE STUDY AND PURSUANT TO THE TRIAL DESIGN WERE FOLLOWED FOR ONE-YEAR TO MONITOR FOR ANY SAFETY ISSUES. THE LAST INFANT FOLLOW-UP VISIT WAS COMPLETED IN EARLY DECEMBER 2010. AFTER A YEAR OF FOLLOWING THE INFANTS, THERE WAS THEN A DATA LOCK ON THE CLINICAL TRIAL INFORMATION IN JUNE OF 2011 FOLLOWED BY THE FINAL CLINICAL STUDY REPORT IN DECEMBER OF 2011. NEO-NATAL DOSING: A KEY ASPECT OF INTL-MEDICA DEVELOPMENT OF ROTASHIELD WAS THE CHANGE OF DOSING FOR ROTAVIRUS VACCINES TO A NEONATAL DOSING SCHEDULE, IE PROVIDING THE FIRST DOSE WITHIN THE FIRST 29 DAYS BIRTHED LIFE AND A SECOND DOSE BEFORE 60 DAYS OF AGE. THE VACCINE WAS ORIGINALLY DEVELOPED WHERE THE FIRST DOSE WOULD BE ADMINISTERED TO INFANTS AT 2 MONTHS OF AGE, IN A THREE DOSE REGIMEN. TO INCREASE THE EFFECTIVENESS OF THE VACCINE WITH FEWER DOSES, AND TO INCREASE THE LIKELIHOOD OF ACCESS OF CHILDREN TO HEALTH PROFESSIONALS IN THE DEVELOPING WORLD, INTERNATIONAL MEDICA DID EXTENSIVE REVIEW INTO THE PREVIOUS DATA AND ESTABLISHED A PROTOCOL TO DETERMINE THE EFFECTIVENESS OF ROTASHIELD WHEN GIVEN IN THIS TWO-DOSE, NEONATAL DELIVERY REGIME. NEONATAL DOSING HAS BECOME A PRACTICE OF GREAT INTEREST IN THE PEDIATRIC VACCINE FIELDS SINCE A SIGNIFICANT NUMBER OF INFANTS DIE FROM VACCINE PREVENTABLE DISEASES WITHIN THE FIRST FEW MONTHS OF LIFE; AND IN THE DEVELOPING WORLD, MOST INFANTS
IRS990/DisregardedEntity00
IRS990/DocumentRetentionPolicy00
IRS990/DonorAdvisedFunds00
IRS990/ElectionOfBoardMembers00
IRS990/EmploymentTaxReturnsFiled01
IRS990/ExcessBenefitTransaction00
IRS990/Expense0497136
IRS990/FamilyOrBusinessRelationship00
IRS990/FederalGrantAuditRequired00
IRS990/FeesForServicesAccounting/ManagementAndGeneral06382
IRS990/FeesForServicesAccounting/Total06382
IRS990/FeesForServicesLegal/ManagementAndGeneral02748
IRS990/FeesForServicesLegal/ProgramServices017124
IRS990/FeesForServicesLegal/Total019872
IRS990/FeesForServicesOther/ProgramServices025000
IRS990/FeesForServicesOther/Total025000
IRS990/FollowSFAS1170X
IRS990/ForeignActivities00
IRS990/ForeignFinancialAccount00
IRS990/ForeignOffice00
IRS990/Form8282PropertyDisposedOf00
IRS990/Form990PartVIISectionA/AverageHoursPerWeek040.00
IRS990/Form990PartVIISectionA/AverageHoursPerWeek140.00
IRS990/Form990PartVIISectionA/AverageHoursPerWeek21.00
IRS990/Form990PartVIISectionA/AverageHoursPerWeek31.00
IRS990/Form990PartVIISectionA/AverageHoursPerWeek41.00
IRS990/Form990PartVIISectionA/AverageHoursPerWeek51.00
IRS990/Form990PartVIISectionA/AverageHoursPerWeek61.00
IRS990/Form990PartVIISectionA/IndividualTrusteeOrDirector0X
IRS990/Form990PartVIISectionA/IndividualTrusteeOrDirector1X
IRS990/Form990PartVIISectionA/IndividualTrusteeOrDirector2X
IRS990/Form990PartVIISectionA/IndividualTrusteeOrDirector3X
IRS990/Form990PartVIISectionA/IndividualTrusteeOrDirector4X
IRS990/Form990PartVIISectionA/IndividualTrusteeOrDirector5X
IRS990/Form990PartVIISectionA/IndividualTrusteeOrDirector6X
IRS990/Form990PartVIISectionA/NamePerson0DR LEONARD RUIZ
IRS990/Form990PartVIISectionA/NamePerson1SCOTT ROSENOW
IRS990/Form990PartVIISectionA/NamePerson2DR FRANKLYN G PRENDERGAST
IRS990/Form990PartVIISectionA/NamePerson3DR STEVEN G REED
IRS990/Form990PartVIISectionA/NamePerson4JAMES HODGE III
IRS990/Form990PartVIISectionA/NamePerson5DR RICHARD HAUGLAND
IRS990/Form990PartVIISectionA/NamePerson6DR ER DICKSON
IRS990/Form990PartVIISectionA/Officer0X
IRS990/Form990PartVIISectionA/Officer1X
IRS990/Form990PartVIISectionA/OtherCompensation023315
IRS990/Form990PartVIISectionA/OtherCompensation119852
IRS990/Form990PartVIISectionA/OtherCompensation20
IRS990/Form990PartVIISectionA/OtherCompensation30
IRS990/Form990PartVIISectionA/OtherCompensation40
IRS990/Form990PartVIISectionA/OtherCompensation50
IRS990/Form990PartVIISectionA/OtherCompensation60
IRS990/Form990PartVIISectionA/ReportableCompFromOrganization0215000
IRS990/Form990PartVIISectionA/ReportableCompFromOrganization1190000
IRS990/Form990PartVIISectionA/ReportableCompFromOrganization20
IRS990/Form990PartVIISectionA/ReportableCompFromOrganization30
IRS990/Form990PartVIISectionA/ReportableCompFromOrganization40
IRS990/Form990PartVIISectionA/ReportableCompFromOrganization50
IRS990/Form990PartVIISectionA/ReportableCompFromOrganization60
IRS990/Form990PartVIISectionA/ReportableCompFromRelatedOrgs00
IRS990/Form990PartVIISectionA/ReportableCompFromRelatedOrgs10
IRS990/Form990PartVIISectionA/ReportableCompFromRelatedOrgs20
IRS990/Form990PartVIISectionA/ReportableCompFromRelatedOrgs30
IRS990/Form990PartVIISectionA/ReportableCompFromRelatedOrgs40
IRS990/Form990PartVIISectionA/ReportableCompFromRelatedOrgs50
IRS990/Form990PartVIISectionA/ReportableCompFromRelatedOrgs60
IRS990/Form990PartVIISectionA/Title0PRESIDENT
IRS990/Form990PartVIISectionA/Title1VP/TREASURER/SECRETARY
IRS990/Form990PartVIISectionA/Title2CHAIRMAN
IRS990/Form990PartVIISectionA/Title3DIRECTOR
IRS990/Form990PartVIISectionA/Title4DIRECTOR
IRS990/Form990PartVIISectionA/Title5DIRECTOR
IRS990/Form990PartVIISectionA/Title6DIRECTOR
IRS990/Form990ProvidedToGoverningBody01
IRS990/FormersListed00
IRS990/FSAudited00
IRS990/FundraisingActivities00
IRS990/FundsToPayPremiums00
IRS990/GainOrLoss/Securities0-5335
IRS990/Gaming00
IRS990/GrantsAndSimilarAmntsCY00
IRS990/GrantsAndSimilarAmntsPriorYear00
IRS990/GrantsToIndividuals00
IRS990/GrantsToOrganizations00
IRS990/GrantToRelatedPerson00
IRS990/GrossAmountSalesAssets/Securities084412
IRS990/GrossReceipts084333
IRS990/GroupReturnForAffiliates00
IRS990/Hospital00
IRS990/IndependentAuditFinancialStmt00
IRS990/IndoorTanningServices00
IRS990/InfoInScheduleOPartIII0X
IRS990/InfoInScheduleOPartVI0X
IRS990/Insurance/ManagementAndGeneral02226
IRS990/Insurance/Total02226
IRS990/InvestmentIncomeCurrentYear0-5414
IRS990/InvestmentIncome/ExclusionAmount0-79
IRS990/InvestmentIncomePriorYear0-116833
IRS990/InvestmentIncome/TotalRevenueColumn0-79
IRS990/InvestmentInJointVenture00
IRS990/InvestmentsPubTradedSecurities/BOY0488396
IRS990/InvestmentsPubTradedSecurities/EOY00
IRS990/LandBldgEquipmentAccumDeprec05428
IRS990/LandBuildingsEquipmentBasis05676
IRS990/LandBuildingsEquipmentBasisNet/BOY0746
IRS990/LandBuildingsEquipmentBasisNet/EOY0248
IRS990/LessCostOthBasisSalesExpenses/Securities089747
IRS990/LoansFromOfficersDirectors/BOY00
IRS990/LoansFromOfficersDirectors/EOY0500000
IRS990/LoanToOfficerOrDQP01
IRS990/LobbyingActivities00
IRS990/LocalChapters00
IRS990/MaterialDiversionOrMisuse00
IRS990/MembersOrStockholders00
IRS990/MethodOfAccountingAccrual0X
IRS990/MinutesOfCommittees01
IRS990/MinutesOfGoverningBody01
IRS990/MissionDescription0INTERNATIONAL MEDICA FOUNDATION IS COMMITTED TO THE DEVELOPMENT OF BETTER HEALTHCARE FOR FAMILIES IN NEED IN NEGLECTED POPULATIONS AROUND THE WORLD. ALL ACTIVITIES OF THE FOUNDATION ARE IN THE FIELD OF MEDICAL RESEARCH RELATED TO THE DEVELOPMENT OF VACCINES AND RELATED PRODUCTS, SERVICES, THERAPEUTICS, DIAGNOSTICS AND DRUG DELIVERY METHODS FOR DISEASES AFFECTING THE WORLD POPULATION WITH PARTICULARLY CATASTROPHIC EFFECTS ON THE LIVES OF FAMILIES IN THE DEVELOPING WORLD.
IRS990/MoreThan5000KToIndividuals00
IRS990/MoreThan5000KToOrganizations00
IRS990/NameOfPrincipalOfficerPerson0DR LEONARD RUIZ
IRS990/NbrIndependentVotingMembers05
IRS990/NbrVotingGoverningBodyMembers07
IRS990/NbrVotingMembersGoverningBody07
IRS990/NetAssetsOrFundBalancesBOY0748889
IRS990/NetAssetsOrFundBalancesEOY018547
IRS990/NetGainOrLossInvestments/ExclusionAmount0-5335
IRS990/NetGainOrLossInvestments/TotalRevenueColumn0-5335
IRS990/NetUnrelatedBusinessTxblIncome00
IRS990/NonDeductibleContributions00
IRS990/NumberFormsTransmittedWith109600
IRS990/NumberIndependentVotingMembers05
IRS990/NumberIndividualsGT100K02
IRS990/NumberOfContractorsGT100K01
IRS990/NumberOfEmployees02
IRS990/NumberW2GIncluded00
IRS990/Occupancy/ProgramServices07032
IRS990/Occupancy/Total07032
IRS990/OfficeExpenses/ManagementAndGeneral04072
IRS990/OfficeExpenses/ProgramServices04072
IRS990/OfficeExpenses/Total08144
IRS990/OfficerEntityWithBsnssRltnshp00
IRS990/OfficerMailingAddress00
IRS990/Organization501c30X
IRS990/OtherEmployeeBenefits/ManagementAndGeneral07295
IRS990/OtherEmployeeBenefits/ProgramServices035872
IRS990/OtherEmployeeBenefits/Total043167
IRS990/OtherExpensePriorYear01064138
IRS990/OtherExpensesCurrentYear0257236
IRS990/OtherExpenses/Description0CONTRACT RESEARCH
IRS990/OtherExpenses/Description1DUES AND MEMBERSHIPS
IRS990/OtherExpenses/Description2MISCELLANEOUS
IRS990/OtherExpenses/ManagementAndGeneral00
IRS990/OtherExpenses/ManagementAndGeneral1350
IRS990/OtherExpenses/ManagementAndGeneral242
IRS990/OtherExpenses/ProgramServices0166143
IRS990/OtherExpenses/ProgramServices10
IRS990/OtherExpenses/ProgramServices20
IRS990/OtherExpenses/Total0166143
IRS990/OtherExpenses/Total1350
IRS990/OtherExpenses/Total242
IRS990/OtherRevenueCurrentYear00
IRS990/OtherRevenuePriorYear00
IRS990/PartialLiquidation00
IRS990/PayrollTaxes/ManagementAndGeneral03390
IRS990/PayrollTaxes/ProgramServices016135
IRS990/PayrollTaxes/Total019525
IRS990/PoliticalActivities00
IRS990/PremiumsPaid00
IRS990/PriorExcessBenefitTransaction00
IRS990/ProfessionalFundraising00
IRS990/ProgramServiceRevenueCY00
IRS990/ProgramServiceRevenuePriorYear00
IRS990/ProhibitedTaxShelterTrans00
IRS990/QuidProQuoContributions00
IRS990/ReconcilationOtherChanges00
IRS990/ReconcilationRevenueExpenses0-730342
IRS990/RegularMonitoringEnforcement01
IRS990/RelatedEntity00
IRS990/RelatedOrgControlledEntity00
IRS990/ReportFin48Footnote00
IRS990/ReportInvestOthSecurities00
IRS990/ReportLandBldgEquip01
IRS990/ReportOtherAssets00
IRS990/ReportOtherLiabilities00
IRS990/ReportProgRelInvest00
IRS990/RevenuesLessExpensesCY0-730342
IRS990/RevenuesLessExpensesPriorYear0-1146620
IRS990/SalariesEtcCurrentYear0467692
IRS990/SalariesEtcPriorYear0465649
IRS990/SavingsAndTempCashInvestments/BOY0127323
IRS990/SavingsAndTempCashInvestments/EOY0515043
IRS990ScheduleA/AmountsSubstContributorsTotal010465335
IRS990ScheduleA/First5Years1700X
IRS990ScheduleA/GiftsGrantsContribReceived170/CurrentTaxYearMinus1Year0500000
IRS990ScheduleA/GiftsGrantsContribReceived170/CurrentTaxYearMinus4Years010184391
IRS990ScheduleA/GiftsGrantsContribReceived170/Total010684391
IRS990ScheduleA/GrossInvestmentIncome170/CurrentTaxYearMinus1Year0563
IRS990ScheduleA/GrossInvestmentIncome170/CurrentTaxYearMinus2Years040317
IRS990ScheduleA/GrossInvestmentIncome170/CurrentTaxYearMinus3Years0102536
IRS990ScheduleA/GrossInvestmentIncome170/CurrentTaxYearMinus4Years0124985
IRS990ScheduleA/GrossInvestmentIncome170/Total0268401
IRS990ScheduleA/PubliclySupportedOrg170b1Avi0X
IRS990ScheduleA/PublicSupportTotal1700219056
IRS990ScheduleA/Total170/CurrentTaxYearMinus1Year0500000
IRS990ScheduleA/Total170/CurrentTaxYearMinus4Years010184391
IRS990ScheduleA/Total170/Total010684391
IRS990ScheduleA/TotalSupport010952792
IRS990/ScheduleBRequired00
IRS990ScheduleD/Equipment/BookValue0248
IRS990ScheduleD/Equipment/Depreciation05428
IRS990ScheduleD/Equipment/OtherCostOrOtherBasis05676
IRS990ScheduleD/TotalOfBookValueLandBuildings0248
IRS990ScheduleJ/AnyNonFixedPayments00
IRS990ScheduleJ/BoardOrCommitteeApproval0X
IRS990ScheduleJ/CompBasedNetEarningsFilingOrg00
IRS990ScheduleJ/CompBasedNetEarningsRelateOrgs00
IRS990ScheduleJ/CompBasedOnRevenueOfFilingOrg00
IRS990ScheduleJ/CompBasedOnRevenueRelatedOrgs00
IRS990ScheduleJ/CompensationCommittee0X
IRS990ScheduleJ/CompensationSurvey0X
IRS990ScheduleJ/EquityBasedCompArrangement00
IRS990ScheduleJ/Form990OfOtherOrganizations0X
IRS990ScheduleJ/Form990ScheduleJPartII/BaseCompensationFilingOrg0215000
IRS990ScheduleJ/Form990ScheduleJPartII/BaseCompensationFilingOrg1190000
IRS990ScheduleJ/Form990ScheduleJPartII/BonusFilingOrg00
IRS990ScheduleJ/Form990ScheduleJPartII/BonusFilingOrg10
IRS990ScheduleJ/Form990ScheduleJPartII/BonusRelatedOrgs00
IRS990ScheduleJ/Form990ScheduleJPartII/BonusRelatedOrgs10
IRS990ScheduleJ/Form990ScheduleJPartII/CompBasedOnRelatedOrgs00
IRS990ScheduleJ/Form990ScheduleJPartII/CompBasedOnRelatedOrgs10
IRS990ScheduleJ/Form990ScheduleJPartII/CompReportPrior990FilingOrg00
IRS990ScheduleJ/Form990ScheduleJPartII/CompReportPrior990FilingOrg10
IRS990ScheduleJ/Form990ScheduleJPartII/CompReportPrior990RelatedOrgs00
IRS990ScheduleJ/Form990ScheduleJPartII/CompReportPrior990RelatedOrgs10
IRS990ScheduleJ/Form990ScheduleJPartII/DeferredCompFilingOrg021500
IRS990ScheduleJ/Form990ScheduleJPartII/DeferredCompFilingOrg119000
IRS990ScheduleJ/Form990ScheduleJPartII/DeferredCompRelatedOrgs00
IRS990ScheduleJ/Form990ScheduleJPartII/DeferredCompRelatedOrgs10
IRS990ScheduleJ/Form990ScheduleJPartII/NamePerson0DR LEONARD RUIZ
IRS990ScheduleJ/Form990ScheduleJPartII/NamePerson1SCOTT ROSENOW
IRS990ScheduleJ/Form990ScheduleJPartII/NontaxableBenefitsFilingOrg01815
IRS990ScheduleJ/Form990ScheduleJPartII/NontaxableBenefitsFilingOrg1852
IRS990ScheduleJ/Form990ScheduleJPartII/NontaxableBenefitsRelatedOrgs00
IRS990ScheduleJ/Form990ScheduleJPartII/NontaxableBenefitsRelatedOrgs10
IRS990ScheduleJ/Form990ScheduleJPartII/OtherCompensationFilingOrg00
IRS990ScheduleJ/Form990ScheduleJPartII/OtherCompensationFilingOrg10
IRS990ScheduleJ/Form990ScheduleJPartII/OtherCompensationRelatedOrgs00
IRS990ScheduleJ/Form990ScheduleJPartII/OtherCompensationRelatedOrgs10
IRS990ScheduleJ/Form990ScheduleJPartII/TotalCompensationFilingOrg0238315
IRS990ScheduleJ/Form990ScheduleJPartII/TotalCompensationFilingOrg1209852
IRS990ScheduleJ/Form990ScheduleJPartII/TotalCompensationRelatedOrgs00
IRS990ScheduleJ/Form990ScheduleJPartII/TotalCompensationRelatedOrgs10
IRS990ScheduleJ/IndependentConsultant0X
IRS990ScheduleJ/InitialContractException00
IRS990/ScheduleJRequired01
IRS990ScheduleJ/SeverancePayment00
IRS990ScheduleJ/SupplementalNonqualRetirePlan00
IRS990ScheduleL/LoanTable/ApprovedByBoard01
IRS990ScheduleL/LoanTable/BalanceDue0500000
IRS990ScheduleL/LoanTable/Default00
IRS990ScheduleL/LoanTable/LoanToOrganization0X
IRS990ScheduleL/LoanTable/NameBusiness/BusinessNameLine10RICHARD P HAUGLAND FOUNDATION
IRS990ScheduleL/LoanTable/OriginalPrincipalAmount0500000
IRS990ScheduleL/LoanTable/PurposeOfLoan0FUND CONTINUED RESEARCH AND DEVELOPMENT OF VACCINES FOR 3RD WORLD COUNTRIES
IRS990ScheduleL/LoanTable/WrittenAgreement01
IRS990ScheduleL/TotalBalanceDue0500000
IRS990ScheduleO/GeneralExplanation/Explanation0EVERY BOARD MEMBER REVIEWS THE DRAFT 990 FORM. ALL QUESTIONS AND COMMENTS ARE DIRECTED TO THE APPROPRIATE PROFESSIONALS. WHEN THE BOARD IS SATISFIED THAT THE FORM 990 ACCURATELY REFLECTS THE ORGANIZATION'S ACTIVITES, IT IS FINALIZED AND FILED.
IRS990ScheduleO/GeneralExplanation/Explanation1EACH DIRECTOR, OFFICER, INDEPENDENT CONTRACTOR (WHICH IS SOLELY RESPONSIBLE FOR PERFORMING AN IMPORTANT OPERATING FUNCTION), OR OTHER SENIOR SUPERVISORY EMPLOYEE, AND ANY PARENTS, LINEAL DESCENDANTS, SIBLINGS AND SPOUSES OF ANY OF THE ABOVE WHO HAS SUCH A DIRECT CONFLICTING INTEREST OR OWNS ANY INTEREST (AS STOCK, A PARTNERSHIP INTEREST OF ANY KIND OR A BENEFICIAL INTEREST IN A TRUST) ("POTENTIALLY DISQUALIFIED PARTIES") WITH RESPECT TO ANY TRANSACTION WHICH HE OR SHE KNOWS IS UNDER CONSIDERATION BY THE BOARD OF DIRECTORS OF THE CORPORATION OR ANY OF ITS COMMITTEES, IS REQUIRED TO MAKE TIMELY DISCLOSURE THEREOF SO THAT IT MAY BE PART OF THE BOARD OF DIRECTORS' CONSIDERATION OF THE TRANSACTION AND THE PERSON HOLDING THE CONFLICTED INTEREST SHALL FURTHER REFRAIN FROM PARTICIPATING IN CONSIDERATION EXCEPT AS DIRECTED BY THE REMAINING MEMBERS OF THE BOARD OF DIRECTORS. IT IS THE RESPONSIBILITY OF THE DIRECTOR, OFFICER, INDEPENDENT CONTRACTOR OR SENIOR SUPERVISORY EMPLOYEE THROUGH WHOM A RELATIVE OR FELLOW BUSINESS ASSOCIATE BECOMES A "POTENTIALLY DISQUALIFIED PARTY" TO SUPPLY A LIST OF PERSONS FALLING WITHIN THIS CATEGORY AT THE BEGINNING OF EACH YEAR ON A FORM PROVIDED BY COUNSEL. ANNUALLY THE BOARD ALSO SUBMITS A BOARD AND KEY EMPLOYEE QUESTIONNAIRE THAT REQUESTS INFORMATION CONCERNING CONFLICTS OF INTEREST AND POTENTIAL CONFLICTS OF INFORMATION. ANY ISSUES RAISED BY THESE QUESTIONNAIRES ARE REVIEWED AND DISCUSSED TO DETERMINE WHETHER ANY CONFLICT OF INTEREST EXISTS AND TO BRING TO RESOLUTION ANY SUCH CONFLICTS.
IRS990ScheduleO/GeneralExplanation/Explanation2THE FOUNDATION FOLLOWS THE PROCESS OUTLINED IN INTERNAL REVENUE CODE SPECIFICALLY CODE SECTIONS 162 AND 4958 FOR NONPROFITS DESCRIBED IN SECTION 501(C)(3) OR SECTION 501(C)(4) TO ESTABLISH A COMPENSATION PACKAGE THAT IS REASONABLE UNDER THE GUIDELINES. INTERNATIONAL MEDICA ESTABLISHED A COMMITTEE ACTING ON BEHALF OF THE GOVERNING BODY TO APPROVE THE COMPENSATION ARRANGEMENT. MEMBERS OF THE COMMITTEE ARE NOT RELATED TO THOSE WHO WILL BE COMPENSATED, OR IN A POSITION TO OBTAIN FINANCIAL BENEFITS FOR THOSE WHO WILL BE COMPENSATED. THE COMMITTEE OBTAINED AND RELIED UPON APPROPRIATE COMPARABILITY DATA PRIOR TO APPROVING THE ARRANGEMENT. THE COMMITTEE THEN DOCUMENTED THE BASIS FOR ITS DETERMINATION CONCURRENTLY WITH MAKING THAT DETERMINATION. THE COMPENSATION ARRANGEMENTS WERE THEN DISCUSSED AND VOTED ON BY THE BOARD OF DIRECTORS OF INTERNATIONAL MEDICA.
IRS990ScheduleO/GeneralExplanation/Explanation3THE FOUNDATION'S FORM 1023 AND FORM 990'S ARE AVAILABLE TO THE PUBLIC UPON REQUEST.
IRS990ScheduleO/GeneralExplanation/Explanation4THE FOUNDATION'S ARTICLES OF INCORPORATION, CONFLICT OF INTEREST POLICY AND AUDITED FINANCIAL STATEMENTS ARE AVAILABLE TO THE PUBLIC UPON REQUEST.
IRS990ScheduleO/GeneralExplanation/ReturnReference0FORM 990, PART VI, SECTION B, LINE 11
IRS990ScheduleO/GeneralExplanation/ReturnReference1FORM 990, PART VI, SECTION B, LINE 12C
IRS990ScheduleO/GeneralExplanation/ReturnReference2FORM 990, PART VI, SECTION B, LINE 15
IRS990ScheduleO/GeneralExplanation/ReturnReference3FORM 990, PART VI, SECTION C, LINE 18
IRS990ScheduleO/GeneralExplanation/ReturnReference4FORM 990, PART VI, SECTION C, LINE 19
IRS990/ScheduleORequired01
IRS990/School00
IRS990/SignificantChange00
IRS990/SignificantNewProgramServices00
IRS990/StateLegalDomicile0MN
IRS990/StatesWhereCopyOfReturnIsFiled0MN
IRS990/SubjectToProxyTax00
IRS990/TaxablePartyNotification00
IRS990/TaxExemptBonds00
IRS990/Terminated00
IRS990/TermOrPermanentEndowments00
IRS990/TheBooksAreInCareOf/AddressUS/AddressLine10421 1ST AVE SUITE 304
IRS990/TheBooksAreInCareOf/AddressUS/City0ROCHESTER
IRS990/TheBooksAreInCareOf/AddressUS/State0MN
IRS990/TheBooksAreInCareOf/AddressUS/ZIPCode055902
IRS990/TheBooksAreInCareOf/NameBusiness/BusinessNameLine10SCOTT ROSENOW
IRS990/TheBooksAreInCareOf/TelephoneNumber05072064380
IRS990/TotalAssets/BOY0748889
IRS990/TotalAssetsBOY0748889
IRS990/TotalAssets/EOY0518547
IRS990/TotalAssetsEOY0518547
IRS990/TotalCompGT150K01
IRS990/TotalExpensesCurrentYear0724928
IRS990/TotalExpensesPriorYear01529787
IRS990/TotalFunctionalExpenses/Fundraising00
IRS990/TotalFunctionalExpenses/ManagementAndGeneral098088
IRS990/TotalFunctionalExpenses/ProgramServices0626840
IRS990/TotalFunctionalExpenses/Total0724928
IRS990/TotalFundrsngExpCurrentYear00
IRS990/TotalGrossUBI00
IRS990/TotalLiabilities/BOY00
IRS990/TotalLiabilitiesBOY00
IRS990/TotalLiabilities/EOY0500000
IRS990/TotalLiabilitiesEOY0500000
IRS990/TotalLiabNetAssetsFundBalances/BOY0748889
IRS990/TotalLiabNetAssetsFundBalances/EOY0518547
IRS990/TotalNbrEmployees02
IRS990/TotalNbrVolunteers011
IRS990/TotalNetAssetsFundBalances/BOY0748889
IRS990/TotalNetAssetsFundBalances/EOY018547
IRS990/TotalOtherCompensation043167
IRS990/TotalProfFundrsngExpCY00
IRS990/TotalProfFundrsngExpPriorYear00
IRS990/TotalProgramServiceExpense0626840
IRS990/TotalReportableCompFrmRltdOrgs00
IRS990/TotalReportableCompFromOrg0405000
IRS990/TotalRevenueCurrentYear0-5414
IRS990/TotalRevenue/ExclusionAmount0-5414
IRS990/TotalRevenuePriorYear0383167
IRS990/TotalRevenue/RelatedOrExemptFunctionIncome00
IRS990/TotalRevenue/TotalRevenueColumn0-5414
IRS990/TotalRevenue/UnrelatedBusinessRevenue00
IRS990/TransactionRelatedEntity00
IRS990/TransfersToExemptNonChrtblOrg00
IRS990/Travel/ManagementAndGeneral02051
IRS990/Travel/ProgramServices019462
IRS990/Travel/Total021513
IRS990/TypeOfOrganizationCorporation0X
IRS990/UnrelatedBusinessIncome00
IRS990/UnrestrictedNetAssets/BOY0748889
IRS990/UnrestrictedNetAssets/EOY018547
IRS990/UponRequest0X
IRS990/WebSite0WWW.INTL-MEDICA.ORG
IRS990/WhistleblowerPolicy00
IRS990/YearFormation02007
ReturnHeader/BuildTS02016-03-07 17:11:31Z
ReturnHeader/Filer/EIN0261556795
ReturnHeader/Filer/Name/BusinessNameLine10INTERNATIONAL MEDICA FOUNDATION
ReturnHeader/Filer/NameControl0INTE
ReturnHeader/Filer/Phone05072064380
ReturnHeader/Filer/USAddress/AddressLine10421 1ST AVENUE SW NO 304
ReturnHeader/Filer/USAddress/City0ROCHESTER
ReturnHeader/Filer/USAddress/State0MN

Document Assets

No mirrored PDF or thumbnail assets are attached yet.

Filings